Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
ABCD3	5825	broad.mit.edu	37	1	94953473	94953473	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:94953473T>C	ENST00000370214.4	+	13	1115	c.1091T>C	c.(1090-1092)cTt>cCt	p.L364P	ABCD3_ENST00000394233.2_Intron|ABCD3_ENST00000454898.2_Missense_Mutation_p.L388P|ABCD3_ENST00000536817.1_Missense_Mutation_p.L291P|ABCD3_ENST00000484213.1_3'UTR	NM_002858.3	NP_002849.1	P28288	ABCD3_HUMAN	ATP-binding cassette, sub-family D (ALD), member 3	364	ABC transmembrane type-1.	NA			peroxisomal long-chain fatty acid import|peroxisome organization	cytosol|integral to peroxisomal membrane	ATP binding|ATPase activity, coupled to transmembrane movement of substances			breast(1)|endometrium(1)|kidney(3)|large_intestine(5)|liver(2)|lung(10)|ovary(1)|pancreas(1)|skin(2)	26		all_lung(203;0.000434)|Lung NSC(277;0.0019)		all cancers(265;0.0261)|Epithelial(280;0.165)		GGAAGAATGCTTTTGCGAATG	0.333	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						96	100	99	NA		NA	NA	1		NA											NA				94953473		2203	4300	6503	SO:0001583	missense			ENSG00000117528	HGNC:67	NM_002858	Approved	uc001dqn.4	NA	D3DT46|Q15271|Q6NUN5|Q96DA3|Q9H529	ENST00000370214.4	37	CCDS749.1	.	.	.	.	.	.	.	.	.	.	T	24.5	4.543856	0.86022	.	.	ENSG00000117528	ENST00000454898;ENST00000536817;ENST00000370214	D;D;D	0.98876	-5.2;-5.2;-5.2	5.83	5.83	0.93111	ABC transporter, transmembrane domain, type 1 (1);	0.000000	0.85682	D	0.000000	D	0.99257	0.9741	M	0.90425	3.115	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.83275	0.996;0.992	D	0.99243	1.0885	10	0.87932	D	0	-15.7972	16.1984	0.82046	0.0:0.0:0.0:1.0	.	388;364	E7EUE1;P28288	.;ABCD3_HUMAN	P	388;291;364	ENSP00000403357:L388P;ENSP00000440692:L291P;ENSP00000359233:L364P	ENSP00000359233:L364P	L	+	2	0	ABCD3	94726061	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	7.694000	0.84235	2.223000	0.72356	0.402000	0.26972	CTT	ABCD3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000029597.1	-0.197042	KEEP		+	21.807692	0.069565	8	107	---	---	---	---	1	0.998392	11	103	0	146	15	155	0	146	2	0	0	0	0	0	0	15	155	0	146	2	TP
NOTCH2	4853	broad.mit.edu	37	1	120464949	120464949	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:120464949G>C	ENST00000256646.2	-	28	5342	c.5123C>G	c.(5122-5124)tCt>tGt	p.S1708C	NOTCH2_ENST00000493703.1_5'Flank	NM_024408.3	NP_077719.2	Q04721	NOTC2_HUMAN	notch 2	1708		NA			anti-apoptosis|bone remodeling|cell cycle arrest|cell fate determination|cell growth|hemopoiesis|induction of apoptosis|negative regulation of cell proliferation|nervous system development|Notch receptor processing|Notch signaling pathway|organ morphogenesis|positive regulation of Ras protein signal transduction|regulation of transcription, DNA-dependent|stem cell maintenance|transcription, DNA-dependent	cell surface|cytosol|endoplasmic reticulum lumen|extracellular region|Golgi lumen|integral to plasma membrane|nucleoplasm	calcium ion binding|ligand-regulated transcription factor activity|protein binding|receptor activity			breast(4)|central_nervous_system(6)|cervix(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(9)|kidney(9)|large_intestine(19)|liver(1)|lung(57)|ovary(4)|pancreas(1)|prostate(7)|skin(24)|stomach(2)|upper_aerodigestive_tract(5)|urinary_tract(1)	158	all_neural(166;0.153)	all_lung(203;1.96e-06)|Lung NSC(69;1.47e-05)|all_epithelial(167;0.000809)		Lung(183;0.0242)|LUSC - Lung squamous cell carcinoma(189;0.133)		CAGCCAGAGAGAGCCATGCTT	0.512	NA	NA	"""N, F, Mis"""		"""marginal zone lymphoma, DLBCL"""			NA	Alagille Syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		1	1p13-p11	4853	Notch homolog 2		L	0							NA						85	82	83	NA		NA	NA	1		NA											NA				120464949		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	ALGS1, ALGS2.Alagille-Watson syndrome	ENSG00000134250	HGNC:7882	NM_024408	Approved	uc001eik.3	NA	Q5T3X7|Q99734|Q9H240	ENST00000256646.2	37	CCDS908.1	.	.	.	.	.	.	.	.	.	.	G	14.82	2.650015	0.47362	.	.	ENSG00000134250	ENST00000256646	D	0.82255	-1.59	5.65	3.56	0.40772	.	0.212991	0.23610	U	0.046345	T	0.59032	0.2164	L	0.51422	1.61	0.26486	N	0.975022	P	0.39624	0.681	B	0.33750	0.169	T	0.51545	-0.8692	10	0.42905	T	0.14	.	7.1146	0.25409	0.1053:0.0:0.7424:0.1524	.	1708	Q04721	NOTC2_HUMAN	C	1708	ENSP00000256646:S1708C	ENSP00000256646:S1708C	S	-	2	0	NOTCH2	120266472	1.000000	0.71417	1.000000	0.80357	0.993000	0.82548	3.891000	0.56227	0.677000	0.31305	0.655000	0.94253	TCT	NOTCH2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033679.1	105.163951	KEEP		-	111.57791	0.267176	35	96	---	---	---	---	1	0.9999999	30	40	0	88	43	109	0	88	2	0	0	0	0	0	0	43	109	0	88	2	TP
SPTA1	6708	broad.mit.edu	37	1	158614180	158614180	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:158614180G>C	ENST00000368148.3	-	30	4381	c.4201C>G	c.(4201-4203)Cag>Gag	p.Q1401E	SPTA1_ENST00000368147.3_Missense_Mutation_p.Q1401E	NM_003126.2	NP_003117.2	P02549	SPTA1_HUMAN	spectrin, alpha, erythrocytic 1 (elliptocytosis 2)	1401		NA			actin filament capping|actin filament organization|axon guidance|regulation of cell shape	cytosol|intrinsic to internal side of plasma membrane|spectrin|spectrin-associated cytoskeleton	actin filament binding|calcium ion binding|structural constituent of cytoskeleton			NS(3)|breast(7)|cervix(1)|endometrium(22)|kidney(9)|large_intestine(29)|liver(2)|lung(183)|ovary(5)|prostate(18)|skin(11)|soft_tissue(1)|stomach(1)|upper_aerodigestive_tract(9)|urinary_tract(6)	307	all_hematologic(112;0.0378)					CAGTTCCCCTGGAACATCTAT	0.453	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						88	85	86	NA		NA	NA	1		NA											NA				158614180		1949	4150	6099	SO:0001583	missense			ENSG00000163554	HGNC:11272	NM_003126	Approved	uc001fst.1	NA	Q15514|Q5VYL1|Q5VYL2|Q6LDY5	ENST00000368148.3	37	CCDS41423.1	.	.	.	.	.	.	.	.	.	.	G	7.760	0.705096	0.15172	.	.	ENSG00000163554	ENST00000368148;ENST00000368147	T;T	0.50001	0.76;0.76	5.03	4.11	0.48088	.	1.727610	0.03930	N	0.285189	T	0.27559	0.0677	L	0.50333	1.59	0.26401	N	0.976427	B	0.11235	0.004	B	0.19946	0.027	T	0.27365	-1.0076	10	0.30854	T	0.27	.	11.9436	0.52915	0.0:0.0:0.6848:0.3152	.	1401	P02549	SPTA1_HUMAN	E	1401	ENSP00000357130:Q1401E;ENSP00000357129:Q1401E	ENSP00000357129:Q1401E	Q	-	1	0	SPTA1	156880804	1.000000	0.71417	0.906000	0.35671	0.186000	0.23388	5.217000	0.65252	1.461000	0.47929	0.591000	0.81541	CAG	SPTA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051851.2	205.99285	KEEP		-	215.166881	0.295082	72	172	---	---	---	---	0	0	0	0	0	96	98	225	0	96	2	1	1	166	264	2	524	98	225	0	96	7	TP
RGL1	23179	broad.mit.edu	37	1	183849845	183849845	+	Missense_Mutation	SNP	A	A	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:183849845A>C	ENST00000304685.3	+	6	1087	c.626A>C	c.(625-627)tAt>tCt	p.Y209S	RGL1_ENST00000360851.3_Missense_Mutation_p.Y174S|RGL1_ENST00000536277.1_Missense_Mutation_p.Y172S|RGL1_ENST00000539189.1_Missense_Mutation_p.Y174S|RGL1_ENST00000367531.1_Missense_Mutation_p.Y209S	NM_015149.3	NP_055964.3	Q9NZL6	RGL1_HUMAN	ral guanine nucleotide dissociation stimulator-like 1	174		NA			cellular lipid metabolic process|regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction	intracellular	protein binding|Ral guanyl-nucleotide exchange factor activity	p.Y209S(2)		breast(5)|cervix(1)|endometrium(3)|kidney(4)|large_intestine(12)|liver(1)|lung(17)|ovary(4)|prostate(3)|stomach(1)	51						CTGCTGGATTATCTCACACGG	0.498	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				2	Substitution - Missense(2)	breast(2)					NA						93	88	90	NA		NA	NA	1		NA											NA				183849845		2203	4300	6503	SO:0001583	missense			ENSG00000143344	HGNC:30281	NM_015149	Approved	uc001gqm.3	NA	Q5SXQ2|Q9HBY3|Q9HBY4|Q9NZL5|Q9UG43|Q9Y2G6	ENST00000304685.3	37	CCDS1359.1	.	.	.	.	.	.	.	.	.	.	A	18.72	3.685175	0.68157	.	.	ENSG00000143344	ENST00000304685;ENST00000367531;ENST00000536277;ENST00000360851;ENST00000539189	T;T;T;T;T	0.32753	1.44;1.44;1.44;1.44;1.44	5.23	4.08	0.47627	Ras guanine nucleotide exchange factor, domain (1);Ras-like guanine nucleotide exchange factor, N-terminal (2);	0.065908	0.64402	D	0.000005	T	0.35158	0.0922	M	0.72479	2.2	0.51012	D	0.999901	B;B;B;B	0.18741	0.002;0.03;0.03;0.03	B;B;B;B	0.21708	0.013;0.036;0.022;0.022	T	0.21552	-1.0242	10	0.87932	D	0	.	12.3767	0.55283	0.8588:0.1412:0.0:0.0	.	174;172;174;209	F5H6U6;B7Z2W5;Q9NZL6;Q5SXQ6	.;.;RGL1_HUMAN;.	S	209;209;172;174;174	ENSP00000303192:Y209S;ENSP00000356501:Y209S;ENSP00000438662:Y172S;ENSP00000354097:Y174S;ENSP00000437355:Y174S	ENSP00000303192:Y209S	Y	+	2	0	RGL1	182116468	1.000000	0.71417	0.971000	0.41717	0.795000	0.44927	6.856000	0.75450	0.898000	0.36418	0.454000	0.30748	TAT	RGL1-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000085481.2	355.605449	KEEP		+	355.622116	0.490196	100	104	---	---	---	---	1	1	25	40	0	147	113	133	0	147	2	0	0	0	0	0	0	113	133	0	147	2	TP
RGL1	23179	broad.mit.edu	37	1	183849848	183849848	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:183849848T>A	ENST00000304685.3	+	6	1090	c.629T>A	c.(628-630)cTc>cAc	p.L210H	RGL1_ENST00000360851.3_Missense_Mutation_p.L175H|RGL1_ENST00000536277.1_Missense_Mutation_p.L173H|RGL1_ENST00000539189.1_Missense_Mutation_p.L175H|RGL1_ENST00000367531.1_Missense_Mutation_p.L210H	NM_015149.3	NP_055964.3	Q9NZL6	RGL1_HUMAN	ral guanine nucleotide dissociation stimulator-like 1	175		NA			cellular lipid metabolic process|regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction	intracellular	protein binding|Ral guanyl-nucleotide exchange factor activity			breast(5)|cervix(1)|endometrium(3)|kidney(4)|large_intestine(12)|liver(1)|lung(17)|ovary(4)|prostate(3)|stomach(1)	51						CTGGATTATCTCACACGGATG	0.488	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						92	87	89	NA		NA	NA	1		NA											NA				183849848		2203	4300	6503	SO:0001583	missense			ENSG00000143344	HGNC:30281	NM_015149	Approved	uc001gqm.3	NA	Q5SXQ2|Q9HBY3|Q9HBY4|Q9NZL5|Q9UG43|Q9Y2G6	ENST00000304685.3	37	CCDS1359.1	.	.	.	.	.	.	.	.	.	.	T	20.3	3.965059	0.74131	.	.	ENSG00000143344	ENST00000304685;ENST00000367531;ENST00000536277;ENST00000360851;ENST00000539189	T;T;T;T;T	0.37915	1.17;1.17;1.17;1.17;1.17	5.34	5.34	0.76211	Ras guanine nucleotide exchange factor, domain (1);Ras-like guanine nucleotide exchange factor, N-terminal (2);	0.000000	0.85682	D	0.000000	T	0.62744	0.2453	M	0.82323	2.585	0.58432	D	0.999994	D;D;D;D	0.76494	0.999;0.999;0.999;0.999	D;P;P;P	0.68483	0.958;0.908;0.908;0.908	T	0.68739	-0.5329	10	0.66056	D	0.02	.	15.6185	0.76787	0.0:0.0:0.0:1.0	.	175;173;175;210	F5H6U6;B7Z2W5;Q9NZL6;Q5SXQ6	.;.;RGL1_HUMAN;.	H	210;210;173;175;175	ENSP00000303192:L210H;ENSP00000356501:L210H;ENSP00000438662:L173H;ENSP00000354097:L175H;ENSP00000437355:L175H	ENSP00000303192:L210H	L	+	2	0	RGL1	182116471	1.000000	0.71417	0.989000	0.46669	0.700000	0.40528	5.993000	0.70616	2.144000	0.66660	0.454000	0.30748	CTC	RGL1-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000085481.2	321.335007	KEEP		+	321.335007	0.5	99	99	---	---	---	---	1	1	24	42	0	143	113	128	0	143	2	0	0	0	0	0	0	113	128	0	143	2	TP
ASPM	259266	broad.mit.edu	37	1	197112574	197112574	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:197112574A>G	ENST00000367409.4	-	3	1064	c.808T>C	c.(808-810)Tct>Cct	p.S270P	ASPM_ENST00000294732.7_Missense_Mutation_p.S270P	NM_018136.4	NP_060606.3	Q8IZT6	ASPM_HUMAN	asp (abnormal spindle) homolog, microcephaly associated (Drosophila)	270		NA			mitosis	cytoplasm|nucleus	calmodulin binding			breast(6)|central_nervous_system(2)|cervix(2)|endometrium(10)|kidney(9)|large_intestine(28)|liver(1)|lung(87)|ovary(5)|pancreas(2)|prostate(6)|skin(4)|urinary_tract(3)	165						TCATTAAAAGAAACTTTTGAA	0.378	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						93	91	92	NA		NA	NA	1		NA											NA				197112574		2203	4299	6502	SO:0001583	missense			ENSG00000066279	HGNC:19048	NM_018136	Approved	uc001gtu.3	NA	Q5VYL3|Q86UX4|Q8IUL2|Q8IZJ7|Q8IZJ8|Q8IZJ9|Q8N4D1|Q9NVS1|Q9NVT6	ENST00000367409.4	37	CCDS1389.1	.	.	.	.	.	.	.	.	.	.	A	3.168	-0.170715	0.06421	.	.	ENSG00000066279	ENST00000367409;ENST00000294732	T;T	0.58940	0.3;1.59	4.78	-3.2	0.05156	.	1.231100	0.05595	N	0.575237	T	0.35856	0.0946	N	0.22421	0.69	0.09310	N	1	B;B	0.22604	0.072;0.0	B;B	0.20384	0.029;0.0	T	0.18650	-1.0330	10	0.38643	T	0.18	.	1.106	0.01693	0.2418:0.2934:0.2953:0.1695	.	270;270	Q4G1H1;Q8IZT6	.;ASPM_HUMAN	P	270	ENSP00000356379:S270P;ENSP00000294732:S270P	ENSP00000294732:S270P	S	-	1	0	ASPM	195379197	0.000000	0.05858	0.082000	0.20525	0.018000	0.09664	-1.280000	0.02804	-0.232000	0.09811	-0.322000	0.08575	TCT	ASPM-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000088256.1	101.484244	KEEP		-	101.487599	0.491525	29	30	---	---	---	---	1	0.489863	3	0	1	231	35	36	1	231	2	0	0	0	0	0	0	35	36	1	231	2	TP
PIK3C2B	5287	broad.mit.edu	37	1	204403608	204403608	+	Silent	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr1:204403608G>A	ENST00000367187.3	-	25	4201	c.3645C>T	c.(3643-3645)ggC>ggT	p.G1215G	RP11-739N20.2_ENST00000443515.1_RNA|PIK3C2B_ENST00000424712.2_Silent_p.G1187G	NM_002646.3	NP_002637.3	O00750	P3C2B_HUMAN	phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta	1215	PI3K/PI4K.	NA			cell communication|phosphatidylinositol-mediated signaling	endoplasmic reticulum|microsome|nucleus|phosphatidylinositol 3-kinase complex|plasma membrane	1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol binding|phosphatidylinositol-4-phosphate 3-kinase activity|protein binding			breast(3)|central_nervous_system(1)|cervix(2)|endometrium(4)|large_intestine(11)|lung(24)|prostate(3)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	52	all_cancers(21;0.00347)|all_neural(3;0.0218)|Glioma(3;0.0382)|all_epithelial(62;0.171)|Breast(84;0.179)|Prostate(682;0.227)		GBM - Glioblastoma multiforme(2;2.69e-45)|all cancers(3;1.66e-30)|KIRC - Kidney renal clear cell carcinoma(13;0.0584)|Kidney(21;0.0934)|BRCA - Breast invasive adenocarcinoma(75;0.143)|Epithelial(59;0.193)			CCAGGAAGCGGCCAAAATCAA	0.527	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						81	63	69	NA		NA	NA	1		NA											NA				204403608		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000133056	HGNC:8972	NM_002646	Approved	uc001haw.3	NA	O95666|Q5SW99	ENST00000367187.3	37	CCDS1446.1																																																																																			PIK3C2B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000087965.1	-600.473294	KEEP		-	11.520616	0.005157	11	2122	---	---	---	---	1	0.06326885	2	73	0	66	13	2644	0	66	2	0	0	0	0	0	0	13	2644	0	66	2	TP
QPCT	25797	broad.mit.edu	37	2	37599531	37599531	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr2:37599531G>A	ENST00000338415.3	+	6	1014	c.856G>A	c.(856-858)Gat>Aat	p.D286N	QPCT_ENST00000537448.1_Missense_Mutation_p.D237N	NM_012413.3	NP_036545.1	Q16769	QPCT_HUMAN	glutaminyl-peptide cyclotransferase	286		NA			peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase|proteolysis	extracellular region	acyltransferase activity|glutaminyl-peptide cyclotransferase activity|peptidase activity|zinc ion binding			central_nervous_system(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(4)|lung(3)|prostate(1)|stomach(2)	17		Ovarian(717;0.051)|all_hematologic(82;0.21)				TTTGCTCAAGGATCACTCTTT	0.358	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						191	188	189	NA		NA	NA	2		NA											NA				37599531		2203	4300	6503	SO:0001583	missense			ENSG00000115828	HGNC:9753		Approved	uc002rqg.3	NA	Q16770|Q3KRG6	ENST00000338415.3	37	CCDS1790.1	.	.	.	.	.	.	.	.	.	.	G	9.041	0.989780	0.18966	.	.	ENSG00000115828	ENST00000338415;ENST00000404976;ENST00000537448;ENST00000444022	T;T;T;T	0.48836	0.8;0.8;0.8;0.8	5.42	3.6	0.41247	Peptidase M28 (1);	0.217310	0.49305	D	0.000146	T	0.25827	0.0629	N	0.13140	0.3	0.39831	D	0.972979	B;B	0.11235	0.001;0.004	B;B	0.16722	0.006;0.016	T	0.08126	-1.0737	10	0.22706	T	0.39	-3.9328	5.8776	0.18838	0.3072:0.0:0.6928:0.0	.	237;286	Q16769-2;Q16769	.;QPCT_HUMAN	N	286;237;237;51	ENSP00000344829:D286N;ENSP00000385391:D237N;ENSP00000441606:D237N;ENSP00000389227:D51N	ENSP00000344829:D286N	D	+	1	0	QPCT	37453035	1.000000	0.71417	1.000000	0.80357	0.953000	0.61014	2.174000	0.42482	1.415000	0.47037	0.655000	0.94253	GAT	QPCT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000218572.2	203.73669	KEEP		+	224.616595	0.234568	76	248	---	---	---	---	1	0.9998892	17	29	0	308	104	339	0	308	2	0	0	0	0	0	0	104	339	0	308	2	TP
EEF1B2	1933	broad.mit.edu	37	2	207025366	207025366	+	Silent	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr2:207025366G>A	ENST00000392222.2	+	2	510	c.135G>A	c.(133-135)ccG>ccA	p.P45P	NDUFS1_ENST00000457011.1_5'Flank|NDUFS1_ENST00000455934.2_5'Flank|NDUFS1_ENST00000423725.1_5'Flank|SNORD51_ENST00000384320.2_RNA|NDUFS1_ENST00000449699.1_5'Flank|NDUFS1_ENST00000440274.1_5'Flank|EEF1B2_ENST00000236957.5_Silent_p.P45P|NDUFS1_ENST00000233190.5_5'Flank|SNORA41_ENST00000384675.1_RNA|EEF1B2_ENST00000392221.1_Silent_p.P45P|NDUFS1_ENST00000432169.1_5'Flank	NM_001959.3	NP_001950.1	P24534	EF1B_HUMAN	eukaryotic translation elongation factor 1 beta 2	45	GST C-terminal.	NA				cytosol|eukaryotic translation elongation factor 1 complex	protein binding|translation elongation factor activity	p.P45P(5)		breast(1)|endometrium(5)|kidney(3)|large_intestine(1)|lung(6)	16						CCAGCCCACCGCCTGCCGACT	0.448	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				5	Substitution - coding silent(5)	kidney(2)|endometrium(2)|lung(1)					NA						109	99	102	NA		NA	NA	2		NA											NA				207025366		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000114942	HGNC:3208	NM_001037663	Approved	uc002vbf.1	NA	A8K795|Q6IBH9	ENST00000392222.2	37	CCDS2367.1																																																																																			EEF1B2-003	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336436.1	14.067789	KEEP		+	14.867213	0.277778	5	13	---	---	---	---	1	1	2	1909	0	143	5	20	0	143	2	0	0	0	0	0	0	5	20	0	143	2	TP
COL6A5	256076	broad.mit.edu	37	3	130174429	130174429	+	Missense_Mutation	SNP	A	A	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr3:130174429A>T	ENST00000265379.6	+	37	7203	c.6709A>T	c.(6709-6711)Agc>Tgc	p.S2237C	COL6A5_ENST00000432398.2_Missense_Mutation_p.S2237C			A8TX70	CO6A5_HUMAN	collagen, type VI, alpha 5	2237	Nonhelical region.	NA			axon guidance|cell adhesion	collagen				endometrium(6)|kidney(4)|large_intestine(8)|lung(19)|pancreas(2)|prostate(3)|stomach(1)|urinary_tract(1)	44						TTACCTTCCAAGCCAAATGTT	0.358	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						63	61	62	NA		NA	NA	3		NA											NA				130174429		1810	4070	5880	SO:0001583	missense			ENSG00000172752	HGNC:26674	NM_153264	Approved	uc010htk.2	NA	A9J6L2|A9J6L4|A9J6L6|A9J6L7|A9J6M0|A9J6M1|A9J6M2|B5MEA7|Q6ZW26|Q8NA36	ENST00000265379.6	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	11.04|11.04	1.521629|1.521629	0.27211|0.27211	.|.	.|.	ENSG00000172752|ENSG00000172752	ENST00000512836|ENST00000432398;ENST00000265379;ENST00000373157;ENST00000512482	.|D;D;T;T	.|0.90197	.|-2.54;-2.63;-1.02;-0.88	4.38|4.38	3.19|3.19	0.36642|0.36642	.|.	.|0.811537	.|0.10661	.|N	.|0.648783	D|D	0.90978|0.90978	0.7163|0.7163	L|L	0.57536|0.57536	1.79|1.79	0.09310|0.09310	N|N	1|1	.|D;D	.|0.61697	.|0.983;0.99	.|P;P	.|0.53313	.|0.533;0.723	T|T	0.81200|0.81200	-0.1041|-0.1041	5|10	.|0.56958	.|D	.|0.05	.|.	7.2197|7.2197	0.25979|0.25979	0.8024:0.0:0.0:0.1976|0.8024:0.0:0.0:0.1976	.|.	.|2237;2237	.|A8TX70;A8TX70-2	.|CO6A5_HUMAN;.	M|C	488|2237;2237;180;72	.|ENSP00000390895:S2237C;ENSP00000265379:S2237C;ENSP00000362250:S180C;ENSP00000424968:S72C	.|ENSP00000265379:S2237C	K|S	+|+	2|1	0|0	COL6A5|COL6A5	131657119|131657119	0.032000|0.032000	0.19561|0.19561	0.002000|0.002000	0.10522|0.10522	0.001000|0.001000	0.01503|0.01503	2.564000|2.564000	0.45931|0.45931	0.792000|0.792000	0.33850|0.33850	-0.344000|-0.344000	0.07964|0.07964	AAG|AGC	COL6A5-201	KNOWN	basic	protein_coding	NA	protein_coding		48.004604	KEEP		+	53.946954	0.219512	18	64	---	---	---	---	1	0.3077845	4	1	0	88	26	94	0	88	2	0	0	0	0	0	0	26	94	0	88	2	TP
TRMT44	152992	broad.mit.edu	37	4	8472818	8472818	+	Silent	SNP	A	A	G			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr4:8472818A>G	ENST00000389737.4	+	10	1935	c.1935A>G	c.(1933-1935)ctA>ctG	p.L645L		NM_152544.2	NP_689757.2			tRNA methyltransferase 44 homolog (S. cerevisiae)	NA		NA									NA						CAGAGAGCCTATCTCTGGCAG	0.532	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						122	140	134	NA		NA	NA	4		NA											NA				8472818		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000155275	HGNC:26653	NM_152544	Approved	uc003glg.2	NA		ENST00000389737.4	37	CCDS3402.2																																																																																			TRMT44-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000359197.2	48.495748	KEEP		+	49.670726	0.333333	16	32	---	---	---	---	1	0.6491197	2	4	0	460	17	34	0	460	2	0	0	0	0	0	0	17	34	0	460	2	TP
CENPE	1062	broad.mit.edu	37	4	104044141	104044141	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr4:104044141T>C	ENST00000265148.3	-	43	7119	c.7030A>G	c.(7030-7032)Aaa>Gaa	p.K2344E	CENPE_ENST00000380026.3_Missense_Mutation_p.K2223E	NM_001813.2	NP_001804.2	Q02224	CENPE_HUMAN	centromere protein E, 312kDa	2344	Kinetochore-binding domain.	NA			blood coagulation|cell division|kinetochore assembly|microtubule-based movement|mitotic chromosome movement towards spindle pole|mitotic metaphase|mitotic metaphase plate congression|mitotic prometaphase|multicellular organismal development|positive regulation of protein kinase activity	condensed chromosome kinetochore|cytosol|microtubule|nucleus|spindle	ATP binding|kinetochore binding|microtubule motor activity			NS(3)|breast(6)|cervix(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(3)|kidney(8)|large_intestine(20)|lung(34)|ovary(5)|pancreas(1)|prostate(2)|skin(3)|stomach(5)|urinary_tract(3)	101				OV - Ovarian serous cystadenocarcinoma(123;2.95e-08)		TGGTAGTTTTTAAATAGTTTT	0.378	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						204	210	208	NA		NA	NA	4		NA											NA				104044141		2203	4300	6503	SO:0001583	missense				HGNC:1856		Approved	uc003hxb.1	NA	A6NKY9|A8K2U7|Q4LE75	ENST00000265148.3	37	CCDS34042.1	.	.	.	.	.	.	.	.	.	.	T	16.29	3.081325	0.55753	.	.	ENSG00000138778	ENST00000265148;ENST00000394771;ENST00000380026	T;T	0.70045	-0.45;-0.45	4.71	2.1	0.27182	.	.	.	.	.	T	0.59582	0.2204	L	0.27053	0.805	0.09310	N	1	B;D	0.55172	0.008;0.97	B;P	0.51833	0.007;0.681	T	0.49466	-0.8937	9	0.56958	D	0.05	.	6.6795	0.23113	0.0:0.2012:0.0:0.7988	.	2223;2344	Q02224-3;Q02224	.;CENPE_HUMAN	E	2344;2308;2223	ENSP00000265148:K2344E;ENSP00000369365:K2223E	ENSP00000265148:K2344E	K	-	1	0	CENPE	104263590	0.005000	0.15991	0.001000	0.08648	0.704000	0.40688	-0.126000	0.10563	0.145000	0.18977	0.260000	0.18958	AAA	CENPE-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		161.988357	KEEP		-	164.034578	0.366412	48	83	---	---	---	---	1	0.7662712	4	3	0	274	51	94	0	274	2	0	0	0	0	0	0	51	94	0	274	2	TP
ING2	3622	broad.mit.edu	37	4	184431464	184431464	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr4:184431464G>A	ENST00000302327.3	+	2	404	c.202G>A	c.(202-204)Gaa>Aaa	p.E68K	ING2_ENST00000434682.2_Missense_Mutation_p.E28K	NM_001564.2	NP_001555.1	Q9H160	ING2_HUMAN	inhibitor of growth family, member 2	68		NA			chromatin modification|positive regulation of transcription, DNA-dependent|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of growth|signal transduction|transcription, DNA-dependent	CCAAT-binding factor complex|Sin3 complex	chromatin binding|DNA binding|protein complex binding|zinc ion binding	p.E68K(1)		breast(1)|endometrium(1)|large_intestine(1)|lung(3)|ovary(1)	7		all_lung(41;5.16e-14)|Lung NSC(41;1.33e-13)|Colorectal(36;0.00139)|Hepatocellular(41;0.00886)|Renal(120;0.00988)|all_hematologic(60;0.0207)|Prostate(90;0.0235)|all_neural(102;0.202)		all cancers(43;1.15e-26)|Epithelial(43;2.98e-22)|OV - Ovarian serous cystadenocarcinoma(60;7.64e-10)|GBM - Glioblastoma multiforme(59;4.22e-06)|Colorectal(24;5.87e-06)|STAD - Stomach adenocarcinoma(60;2.09e-05)|COAD - Colon adenocarcinoma(29;5.15e-05)|LUSC - Lung squamous cell carcinoma(40;0.00902)|READ - Rectum adenocarcinoma(43;0.155)		TGATGTCTACGAAAAATATAA	0.318	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				1	Substitution - Missense(1)	large_intestine(1)					NA						84	99	94	NA		NA	NA	4		NA											NA				184431464		2192	4293	6485	SO:0001583	missense			ENSG00000168556	HGNC:6063	NM_001564	Approved	uc003ivs.1	NA	O95698	ENST00000302327.3	37	CCDS3833.1	.	.	.	.	.	.	.	.	.	.	G	18.09	3.545290	0.65198	.	.	ENSG00000168556	ENST00000302327;ENST00000412117;ENST00000434682	.	.	.	5.54	5.54	0.83059	Double Clp-N motif (1);Inhibitor of growth protein, N-terminal (1);	0.000000	0.85682	D	0.000000	D	0.83760	0.5324	M	0.86420	2.815	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.79784	0.993;0.989	T	0.80301	-0.1440	9	0.21540	T	0.41	-17.2433	19.6745	0.95926	0.0:0.0:1.0:0.0	.	28;68	B6ZDS1;Q9H160	.;ING2_HUMAN	K	68;28;28	.	ENSP00000307183:E68K	E	+	1	0	ING2	184668458	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	9.222000	0.95196	2.880000	0.98712	0.650000	0.86243	GAA	ING2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000318652.1	5.576603	KEEP		+	10.461498	0.117647	4	30	---	---	---	---	1	0.973074	13	32	0	237	6	37	0	237	2	0	0	0	0	0	0	6	37	0	237	2	TP
FAM81B	153643	broad.mit.edu	37	5	94749817	94749817	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr5:94749817T>A	ENST00000283357.5	+	4	506	c.460T>A	c.(460-462)Tcg>Acg	p.S154T		NM_152548.2	NP_689761.2	Q96LP2	FA81B_HUMAN	family with sequence similarity 81, member B	154		NA								central_nervous_system(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(7)|lung(4)|ovary(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	22		all_cancers(142;1.1e-06)|all_epithelial(76;1.48e-09)|all_lung(232;0.000696)|Lung NSC(167;0.000947)|Ovarian(225;0.00473)		all cancers(79;1.04e-16)		AAAAGAGGAATCGCTCGCCAG	0.478	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						98	99	99	NA		NA	NA	5		NA											NA				94749817		1989	4168	6157	SO:0001583	missense			ENSG00000153347	HGNC:26335	NM_152548	Approved	uc003kla.1	NA		ENST00000283357.5	37	CCDS43341.1	.	.	.	.	.	.	.	.	.	.	T	3.859	-0.030356	0.07543	.	.	ENSG00000153347	ENST00000283357	T	0.18338	2.22	5.53	0.0654	0.14356	.	0.642786	0.15384	N	0.265144	T	0.07818	0.0196	L	0.28344	0.845	0.09310	N	1	B	0.22800	0.075	B	0.19946	0.027	T	0.32508	-0.9904	10	0.14252	T	0.57	1.7557	1.1738	0.01831	0.2335:0.1461:0.1224:0.498	.	154	Q96LP2	FA81B_HUMAN	T	154	ENSP00000283357:S154T	ENSP00000283357:S154T	S	+	1	0	FAM81B	94775573	0.000000	0.05858	0.088000	0.20740	0.006000	0.05464	-0.273000	0.08548	0.371000	0.24564	0.528000	0.53228	TCG	FAM81B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000370690.1	148.376764	KEEP		+	152.648229	0.324841	51	106	---	---	---	---	1	0.9998377	13	18	0	132	60	122	0	132	2	0	0	0	0	0	0	60	122	0	132	2	TP
GABRA1	2554	broad.mit.edu	37	5	161324318	161324318	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr5:161324318C>T	ENST00000428797.2	+	11	1616	c.1261C>T	c.(1261-1263)Cga>Tga	p.R421*	GABRA1_ENST00000444819.1_Nonsense_Mutation_p.R421*|GABRA1_ENST00000420560.1_Nonsense_Mutation_p.R421*|GABRA1_ENST00000437025.2_Nonsense_Mutation_p.R421*|GABRA1_ENST00000023897.6_Nonsense_Mutation_p.R421*|GABRA1_ENST00000393943.4_Nonsense_Mutation_p.R421*	NM_001127643.1	NP_001121115.1	P14867	GBRA1_HUMAN	gamma-aminobutyric acid (GABA) A receptor, alpha 1	421		NA			gamma-aminobutyric acid signaling pathway|synaptic transmission	cell junction|chloride channel complex|integral to plasma membrane|postsynaptic membrane	chloride channel activity|extracellular ligand-gated ion channel activity|GABA-A receptor activity			NS(1)|endometrium(2)|kidney(3)|large_intestine(4)|liver(1)|lung(22)|ovary(2)|pancreas(2)|prostate(1)|skin(3)|urinary_tract(1)	42	Renal(175;0.00259)	Medulloblastoma(196;0.0208)|all_neural(177;0.0672)	Kidney(164;7.83e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000525)	all cancers(165;0.228)	Alprazolam(DB00404)|Butabarbital(DB00237)|Butalbital(DB00241)|Butethal(DB01353)|Chlordiazepoxide(DB00475)|Clobazam(DB00349)|Clonazepam(DB01068)|Clorazepate(DB00628)|Desflurane(DB01189)|Diazepam(DB00829)|Enflurane(DB00228)|Ethanol(DB00898)|Ethchlorvynol(DB00189)|Etomidate(DB00292)|Flumazenil(DB01205)|Flurazepam(DB00690)|Halazepam(DB00801)|Halothane(DB01159)|Hexobarbital(DB01355)|Isoflurane(DB00753)|Lorazepam(DB00186)|Meprobamate(DB00371)|Metharbital(DB00463)|Methohexital(DB00474)|Methoxyflurane(DB01028)|Methylphenobarbital(DB00849)|Methyprylon(DB01107)|Midazolam(DB00683)|Nitrazepam(DB01595)|Oxazepam(DB00842)|Pentobarbital(DB00312)|Phenobarbital(DB01174)|Picrotoxin(DB00466)|Prazepam(DB01588)|Primidone(DB00794)|Progabide(DB00837)|Propofol(DB00818)|Quazepam(DB01589)|Secobarbital(DB00418)|Sevoflurane(DB01236)|Talbutal(DB00306)|Thiamylal(DB01154)|Thiopental(DB00599)|Topiramate(DB00273)|Zaleplon(DB00962)|Zolpidem(DB00425)	CAAAATTGACCGACTGTCAAG	0.443	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						151	150	150	NA		NA	NA	5		NA											NA				161324318		2203	4300	6503	SO:0001587	stop_gained			ENSG00000022355	HGNC:4075	NM_000806.5	Approved	uc003lyx.4	NA	D3DQK6|Q8N629	ENST00000428797.2	37	CCDS4357.1	.	.	.	.	.	.	.	.	.	.	C	38	7.054540	0.98032	.	.	ENSG00000022355	ENST00000023897;ENST00000428797;ENST00000393943;ENST00000437025;ENST00000420560;ENST00000444819	.	.	.	5.32	4.44	0.53790	.	0.062197	0.64402	D	0.000006	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	15.6781	0.77344	0.1382:0.8618:0.0:0.0	.	.	.	.	X	421	.	ENSP00000023897:R421X	R	+	1	2	GABRA1	161256896	1.000000	0.71417	0.991000	0.47740	0.983000	0.72400	2.534000	0.45676	1.354000	0.45846	0.563000	0.77884	CGA	GABRA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252702.2	268.86539	KEEP		+	269.106869	0.460227	81	95	---	---	---	---	0	0.8365945	0	6	0	247	100	121	0	247	2	1	1	235	278	0	527	100	121	0	247	2	TP
HDAC2	3066	broad.mit.edu	37	6	114265495	114265495	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr6:114265495G>C	ENST00000519065.1	-	11	1547	c.1171C>G	c.(1171-1173)Cat>Gat	p.H391D	HDAC2_ENST00000519108.1_Missense_Mutation_p.H361D|HDAC2_ENST00000368632.2_Missense_Mutation_p.H361D|HDAC2_ENST00000398283.2_Missense_Mutation_p.H485D			Q92769	HDAC2_HUMAN	histone deacetylase 2	391		NA			blood coagulation|dendrite development|embryonic digit morphogenesis|epidermal cell differentiation|eyelid development in camera-type eye|fungiform papilla formation|hair follicle placode formation|maintenance of chromatin silencing|negative regulation of apoptosis|negative regulation of cell cycle|negative regulation of neuron projection development|negative regulation of sequence-specific DNA binding transcription factor activity|negative regulation of transcription from RNA polymerase II promoter|nerve growth factor receptor signaling pathway|odontogenesis of dentine-containing tooth|positive regulation of cell proliferation|positive regulation of proteolysis|positive regulation of receptor biosynthetic process|positive regulation of transcription from RNA polymerase II promoter	cytoplasm|ESC/E(Z) complex|NuRD complex|Sin3 complex	chromatin binding|enzyme binding|histone deacetylase activity (H3-K16 specific)|NAD-dependent histone deacetylase activity (H3-K14 specific)|NAD-dependent histone deacetylase activity (H3-K9 specific)|NAD-dependent histone deacetylase activity (H4-K16 specific)|sequence-specific DNA binding|transcription factor binding			biliary_tract(1)|central_nervous_system(5)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(11)|ovary(1)|prostate(1)|skin(2)	27		all_cancers(87;0.000629)|all_epithelial(87;0.00274)|Colorectal(196;0.0317)|all_lung(197;0.24)		all cancers(137;0.00318)|OV - Ovarian serous cystadenocarcinoma(136;0.00569)|Epithelial(106;0.0112)|GBM - Glioblastoma multiforme(226;0.0832)	Vorinostat(DB02546)	CTGTCTTCATGAACAGCATCT	0.363	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						129	120	123	NA		NA	NA	6		NA											NA				114265495		1910	4143	6053	SO:0001583	missense			ENSG00000196591	HGNC:4853		Approved	uc003pwd.2	NA	B4DL58|E1P561|Q5SRI8|Q5SZ86|Q8NEH4	ENST00000519065.1	37	CCDS43493.2	.	.	.	.	.	.	.	.	.	.	G	13.14	2.147074	0.37923	.	.	ENSG00000196591	ENST00000519065;ENST00000398283;ENST00000519108;ENST00000368632	T;T;T;T	0.72942	-0.68;-0.7;-0.68;-0.68	6.07	6.07	0.98685	.	0.078024	0.53938	D	0.000046	T	0.28599	0.0708	N	0.00670	-1.27	0.58432	D	0.999991	B;B	0.02656	0.0;0.0	B;B	0.04013	0.001;0.001	T	0.31998	-0.9923	10	0.25751	T	0.34	-37.0655	20.6439	0.99570	0.0:0.0:1.0:0.0	.	361;391	B3KRS5;Q92769	.;HDAC2_HUMAN	D	391;485;361;361	ENSP00000430432:H391D;ENSP00000381331:H485D;ENSP00000430008:H361D;ENSP00000357621:H361D	ENSP00000357621:H361D	H	-	1	0	HDAC2	114372188	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	9.700000	0.98707	2.884000	0.98904	0.655000	0.94253	CAT	HDAC2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041909.2	130.827058	KEEP		-	132.184527	0.376238	38	63	---	---	---	---	1	1	143	180	0	167	59	87	0	167	2	0	0	0	0	0	0	59	87	0	167	2	TP
MAP7	9053	broad.mit.edu	37	6	136682257	136682257	+	Silent	SNP	C	C	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr6:136682257C>T	ENST00000354570.3	-	12	1997	c.1587G>A	c.(1585-1587)gaG>gaA	p.E529E	MAP7_ENST00000544465.1_Silent_p.E514E|MAP7_ENST00000438100.2_Silent_p.E514E|MAP7_ENST00000432797.2_Silent_p.E383E|MAP7_ENST00000454590.1_Silent_p.E551E	NM_001198616.1|NM_001198617.1|NM_001198619.1|NM_003980.4	NP_001185545.1|NP_001185546.1|NP_001185548.1|NP_003971.1	Q14244	MAP7_HUMAN	microtubule-associated protein 7	529		NA			establishment or maintenance of cell polarity|microtubule cytoskeleton organization|protein localization in plasma membrane|response to osmotic stress	basolateral plasma membrane|microtubule|microtubule associated complex|nucleus|perinuclear region of cytoplasm	receptor binding|structural molecule activity			endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(10)|lung(11)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	33	Colorectal(23;0.24)			GBM - Glioblastoma multiforme(68;0.00199)|OV - Ovarian serous cystadenocarcinoma(155;0.00643)		TGCGCGACTCCTCCTCACGGC	0.617	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						21	24	23	NA		NA	NA	6		NA											NA				136682257		2200	4290	6490	SO:0001819	synonymous_variant			ENSG00000135525	HGNC:6869	NM_003980	Approved	uc011edg.2	NA	Q7Z6S0|Q8TAU5|Q9NY82|Q9NY83	ENST00000354570.3	37	CCDS5178.1																																																																																			MAP7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000042382.2	8.31715	KEEP		-	9.372418	0.214286	3	11	---	---	---	---	1	0.9279502	6	9	0	33	5	13	0	33	2	0	0	0	0	0	0	5	13	0	33	2	TP
CHN2	1124	broad.mit.edu	37	7	29539600	29539600	+	Missense_Mutation	SNP	A	A	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr7:29539600A>C	ENST00000222792.6	+	9	1387	c.857A>C	c.(856-858)cAc>cCc	p.H286P	CHN2_ENST00000495789.2_Missense_Mutation_p.H299P|CHN2_ENST00000409041.4_Missense_Mutation_p.H150P|CHN2_ENST00000421775.2_Intron|CHN2_ENST00000435288.2_Intron|CHN2_ENST00000424025.2_Missense_Mutation_p.H105P|CHN2_ENST00000410098.1_3'UTR|CHN2_ENST00000546235.1_Missense_Mutation_p.H271P|CHN2_ENST00000439711.2_Missense_Mutation_p.H150P|CHN2_ENST00000539389.1_Missense_Mutation_p.H142P|CHN2_ENST00000539406.1_Missense_Mutation_p.H361P	NM_004067.2	NP_004058.1	P52757	CHIO_HUMAN	chimerin 2	286	Rho-GAP.	NA			regulation of small GTPase mediated signal transduction|small GTPase mediated signal transduction	cytosol|membrane	GTPase activator activity|metal ion binding|SH3/SH2 adaptor activity			breast(2)|endometrium(3)|large_intestine(2)|lung(12)|ovary(2)|urinary_tract(2)	23						GTGAAGGCTCACAACACTCAG	0.413	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Ovarian(1;44 48 13232 18918 31480)					NA		NA				0							NA						97	85	89	NA		NA	NA	7		NA											NA				29539600		2203	4300	6503	SO:0001583	missense			ENSG00000106069	HGNC:1944	NM_004067	Approved	uc003szz.3	NA	Q2M203|Q75MM2	ENST00000222792.6	37	CCDS5420.1	.	.	.	.	.	.	.	.	.	.	A	23.1	4.369511	0.82463	.	.	ENSG00000106069	ENST00000539406;ENST00000222792;ENST00000495789;ENST00000539389;ENST00000546235;ENST00000446446;ENST00000409041;ENST00000424025;ENST00000439711	T;T;T;T;T;T;T;T;T	0.10960	2.82;2.82;2.82;2.82;2.82;2.82;2.82;2.82;2.82	5.61	5.61	0.85477	Rho GTPase-activating protein domain (2);Rho GTPase activation protein (1);	0.000000	0.85682	D	0.000000	T	0.35189	0.0923	M	0.76838	2.35	0.80722	D	1	D;B;D;D;D;D;D;B;D;D;D;D;D;D	0.71674	0.994;0.26;0.992;0.998;0.994;0.993;0.998;0.382;0.994;0.996;0.971;0.966;0.994;0.971	P;B;D;D;D;P;D;B;P;P;P;P;D;P	0.79108	0.898;0.064;0.971;0.992;0.917;0.904;0.991;0.133;0.898;0.864;0.896;0.703;0.917;0.896	T	0.10064	-1.0646	10	0.72032	D	0.01	.	15.758	0.78051	1.0:0.0:0.0:0.0	.	79;271;299;361;105;105;150;150;150;142;286;56;150;286	B7Z215;B7Z1W9;B7Z1V0;F5H003;B3VCF1;B3VCF2;B3VCF5;B3VCF7;B3VCF6;B3VCG1;A4D1A2;B3VCF8;E9PGE0;P52757	.;.;.;.;.;.;.;.;.;.;.;.;.;CHIO_HUMAN	P	361;286;299;142;271;111;150;105;150	ENSP00000444063:H361P;ENSP00000222792:H286P;ENSP00000438587:H299P;ENSP00000440526:H142P;ENSP00000442812:H271P;ENSP00000396867:H111P;ENSP00000386849:H150P;ENSP00000406337:H105P;ENSP00000387425:H150P	ENSP00000222792:H286P	H	+	2	0	CHN2	29506125	1.000000	0.71417	1.000000	0.80357	0.972000	0.66771	9.251000	0.95483	2.263000	0.75096	0.379000	0.24179	CAC	CHN2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000214228.2	113.985645	KEEP		+	130.780122	0.207547	44	168	---	---	---	---	1	0.9908286	3	26	0	73	53	190	0	73	2	0	0	0	0	0	0	53	190	0	73	2	TP
EGFR	1956	broad.mit.edu	37	7	55210075	55210075	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr7:55210075T>G	ENST00000275493.2	+	2	362	c.185T>G	c.(184-186)cTt>cGt	p.L62R	EGFR_ENST00000342916.3_Missense_Mutation_p.L62R|EGFR_ENST00000455089.1_Missense_Mutation_p.L62R|EGFR_ENST00000344576.2_Missense_Mutation_p.L62R|EGFR_ENST00000420316.2_Missense_Mutation_p.L62R|EGFR_ENST00000442591.1_Missense_Mutation_p.L62R|EGFR_ENST00000454757.2_Missense_Mutation_p.L9R	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	62		NA			activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.L62R(3)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GAGGTGGTCCTTGGGAATTTG	0.408	NA	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC		NA	Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""		"""E, O"""	3	Substitution - Missense(3)	lung(2)|central_nervous_system(1)					NA						175	167	170	NA		NA	NA	7		NA											NA				55210075		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	T	19.51	3.842145	0.71488	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000450046;ENST00000454757	T;T;T;T;T;T;T;T	0.79454	-1.27;-1.27;-1.27;-1.27;-1.27;-1.27;-1.27;-1.27	6.05	4.9	0.64082	EGF receptor, L domain (1);	0.059356	0.64402	D	0.000001	D	0.87857	0.6283	M	0.86028	2.79	0.54753	D	0.999982	P;P;D;D;D	0.89917	0.882;0.795;1.0;0.991;0.992	P;P;D;P;P	0.74674	0.626;0.553;0.984;0.825;0.814	D	0.88586	0.3140	10	0.72032	D	0.01	.	11.1407	0.48400	0.0:0.0723:0.0:0.9277	.	62;62;62;62;62	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	R	62;62;62;62;62;62;9;9	ENSP00000415559:L62R;ENSP00000342376:L62R;ENSP00000345973:L62R;ENSP00000413843:L62R;ENSP00000275493:L62R;ENSP00000410031:L62R;ENSP00000413354:L9R;ENSP00000395243:L9R	ENSP00000275493:L62R	L	+	2	0	EGFR	55177569	1.000000	0.71417	0.981000	0.43875	0.771000	0.43674	5.950000	0.70265	1.114000	0.41781	-0.263000	0.10527	CTT	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	8109.982115	KEEP		+	8384.925506	0.949508	2219	118	---	---	---	---	1	1	1118	42	2	233	2718	144	2	233	24	1	1	451	35	0	392	2718	144	2	233	2	TP
CCT6P1	0	broad.mit.edu	37	7	65228310	65228310	+	RNA	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr7:65228310G>A	ENST00000442266.1	+	0	1284										NA		NA									NA						GAGATCATGCGAGCTGGAATC	0.418	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA										NA		ENST00000442266.1	37																																																																																				CCT6P1-003	KNOWN	basic	processed_transcript	NA	pseudogene	OTTHUMT00000345507.1	10.133499	KEEP		+	42.455963	0.089474	17	173	---	---	---	---	1	0.8147122	7	34	0	225	19	243	0	225	2	0	0	0	0	0	0	19	243	0	225	2	TP
GCC1	79571	broad.mit.edu	37	7	127222169	127222169	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr7:127222169G>C	ENST00000321407.2	-	2	2651	c.2227C>G	c.(2227-2229)Ctc>Gtc	p.L743V	GCC1_ENST00000497650.1_5'Flank	NM_024523.5	NP_078799.2	Q96CN9	GCC1_HUMAN	GRIP and coiled-coil domain containing 1	743	GRIP.	NA				Golgi membrane|plasma membrane	protein binding			breast(2)|endometrium(6)|kidney(4)|large_intestine(6)|lung(13)|ovary(2)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	38						ATGGCTGTGAGAGTCTGCTGG	0.542	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						196	193	194	NA		NA	NA	7		NA											NA				127222169		2203	4300	6503	SO:0001583	missense			ENSG00000179562	HGNC:19095	NM_024523	Approved	uc003vma.3	NA	Q9H6N7	ENST00000321407.2	37	CCDS5796.1	.	.	.	.	.	.	.	.	.	.	G	21.1	4.091836	0.76756	.	.	ENSG00000179562	ENST00000321407	T	0.17213	2.29	5.87	5.87	0.94306	GRIP (4);	0.000000	0.85682	D	0.000000	T	0.30198	0.0757	N	0.21545	0.675	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	T	0.01124	-1.1444	10	0.44086	T	0.13	-9.5481	18.0718	0.89410	0.0:0.0:1.0:0.0	.	743	Q96CN9	GCC1_HUMAN	V	743	ENSP00000318821:L743V	ENSP00000318821:L743V	L	-	1	0	GCC1	127009405	1.000000	0.71417	0.984000	0.44739	0.986000	0.74619	7.317000	0.79018	2.941000	0.99782	0.655000	0.94253	CTC	GCC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000059911.3	17.064444	KEEP		-	23.250867	0.150943	8	45	---	---	---	---	1	0.9960001	5	45	0	154	15	75	0	154	2	0	0	0	0	0	0	15	75	0	154	2	TP
PTK2B	2185	broad.mit.edu	37	8	27308400	27308400	+	Silent	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr8:27308400G>A	ENST00000397501.1	+	30	3283	c.2475G>A	c.(2473-2475)gaG>gaA	p.E825E	PTK2B_ENST00000517339.1_Silent_p.E783E|PTK2B_ENST00000397497.4_Silent_p.E529E|PTK2B_ENST00000346049.5_Silent_p.E825E|PTK2B_ENST00000420218.2_Silent_p.E783E|PTK2B_ENST00000338238.4_Silent_p.E783E|PTK2B_ENST00000544172.1_Silent_p.E825E	NM_173174.2	NP_775266.1	Q14289	FAK2_HUMAN	protein tyrosine kinase 2 beta	825	Interaction with TGFB1I1 (By similarity).	NA			apoptosis|bone resorption|positive regulation of cell proliferation|signal complex assembly	cytosol	ATP binding|non-membrane spanning protein tyrosine kinase activity|signal transducer activity			breast(2)|central_nervous_system(2)|endometrium(3)|kidney(1)|large_intestine(2)|lung(17)|ovary(4)|skin(12)|soft_tissue(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	47		Ovarian(32;2.72e-05)		UCEC - Uterine corpus endometrioid carcinoma (27;0.023)|Epithelial(17;6.61e-10)|BRCA - Breast invasive adenocarcinoma(99;0.226)|Colorectal(74;0.229)		TCAGGCAGGAGGAGAAGTCCC	0.607	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						96	85	89	NA		NA	NA	8		NA											NA				27308400		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000120899	HGNC:9612	NM_004103	Approved	uc003xfp.2	NA	D3DST0|Q13475|Q14290|Q16709	ENST00000397501.1	37	CCDS6057.1																																																																																			PTK2B-009	PUTATIVE	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000219916.1	38.424482	KEEP		+	39.171616	0.342857	12	23	---	---	---	---	1	0.9999999	33	47	0	69	15	29	0	69	2	0	0	0	0	0	0	15	29	0	69	2	TP
JPH1	56704	broad.mit.edu	37	8	75227467	75227467	+	Silent	SNP	C	C	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr8:75227467C>T	ENST00000342232.4	-	2	808	c.768G>A	c.(766-768)acG>acA	p.T256T		NM_020647.2	NP_065698.1	Q9HDC5	JPH1_HUMAN	junctophilin 1	256	Ser-rich.	NA			calcium ion transport into cytosol|regulation of ryanodine-sensitive calcium-release channel activity	integral to membrane|junctional membrane complex|junctional sarcoplasmic reticulum membrane|plasma membrane				endometrium(4)|kidney(1)|large_intestine(4)|lung(10)|ovary(2)|skin(1)|upper_aerodigestive_tract(2)	24	Breast(64;0.00576)		BRCA - Breast invasive adenocarcinoma(89;0.0499)|Epithelial(68;0.0728)|all cancers(69;0.176)			CAAAGCTGATCGTGGAGTTGG	0.557	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						91	86	88	NA		NA	NA	8		NA											NA				75227467		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000104369	HGNC:14201		Approved	uc003yae.3	NA	B2RTZ0	ENST00000342232.4	37	CCDS6217.1																																																																																			JPH1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000379102.1	52.702665	KEEP		-	52.731785	0.533333	16	14	---	---	---	---	1	0.9995164	7	8	0	138	18	14	0	138	2	0	0	0	0	0	0	18	14	0	138	2	TP
NUP214	8021	broad.mit.edu	37	9	134016058	134016058	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr9:134016058C>T	ENST00000359428.5	+	11	1399	c.1255C>T	c.(1255-1257)Cga>Tga	p.R419*	RP11-544A12.4_ENST00000590461.1_RNA|RP11-544A12.4_ENST00000587408.1_RNA|RP11-544A12.4_ENST00000589667.1_RNA|RP11-544A12.4_ENST00000587264.1_RNA|RP11-544A12.4_ENST00000415391.2_RNA|RP11-544A12.4_ENST00000586290.1_RNA|NUP214_ENST00000451030.1_Nonsense_Mutation_p.R419*|NUP214_ENST00000411637.2_Nonsense_Mutation_p.R419*|RP11-544A12.4_ENST00000589540.1_RNA|RP11-544A12.4_ENST00000588378.1_RNA			P35658	NU214_HUMAN	nucleoporin 214kDa	419		NA			carbohydrate metabolic process|glucose transport|mRNA metabolic process|protein export from nucleus|regulation of glucose transport|transmembrane transport|viral reproduction	cytosol|nuclear pore|nucleoplasm	protein binding			NS(1)|breast(9)|central_nervous_system(3)|endometrium(13)|kidney(2)|large_intestine(9)|liver(2)|lung(29)|ovary(2)|prostate(3)|skin(7)|stomach(2)|upper_aerodigestive_tract(2)|urinary_tract(2)	86	all_hematologic(7;0.0028)	Myeloproliferative disorder(178;0.204)		OV - Ovarian serous cystadenocarcinoma(145;3.42e-05)|Epithelial(140;0.000256)		AACACCAGAGCGACTTTCATT	0.433	NA	NA	T	"""DEK, SET, ABL1"""	"""AML, T-ALL"""			NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(4;24 48 25510 30394 32571)		Dom	yes		9	9q34.1	8021	nucleoporin 214kDa (CAN)		L	0							NA						113	110	111	NA		NA	NA	9		NA											NA				134016058		2203	4300	6503	SO:0001587	stop_gained			ENSG00000126883	HGNC:8064	NM_005085	Approved	uc004cag.3	NA	A6NFQ0|Q15010|Q3KQZ0|Q5JUP7|Q75R47|Q86XD3	ENST00000359428.5	37	CCDS6940.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	27.3|27.3	4.823364|4.823364	0.90873|0.90873	.|.	.|.	ENSG00000126883|ENSG00000126883	ENST00000530863|ENST00000359428;ENST00000411637;ENST00000451030;ENST00000541375	.|.	.|.	.|.	5.91|5.91	4.99|4.99	0.66335|0.66335	.|.	.|0.896444	.|0.09179	.|N	.|0.837770	T|.	0.46073|.	0.1374|.	.|.	.|.	.|.	0.80722|0.80722	A|A	1|1	.|.	.|.	.|.	.|.	.|.	.|.	T|.	0.40496|.	-0.9560|.	3|.	.|0.10377	.|T	.|0.69	-30.1883|-30.1883	15.0046|15.0046	0.71501|0.71501	0.154:0.846:0.0:0.0|0.154:0.846:0.0:0.0	.|.	.|.	.|.	.|.	V|X	90|419	.|.	.|ENSP00000352400:R419X	A|R	+|+	2|1	0|2	NUP214|NUP214	133005879|133005879	0.005000|0.005000	0.15991|0.15991	0.832000|0.832000	0.32986|0.32986	0.059000|0.059000	0.15707|0.15707	0.402000|0.402000	0.20965|0.20965	1.445000|1.445000	0.47624|0.47624	0.655000|0.655000	0.94253|0.94253	GCG|CGA	NUP214-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054694.2	230.558736	KEEP		+	230.862649	0.453416	73	88	---	---	---	---	1	0.9935598	5	8	0	165	87	108	0	165	2	0	0	0	0	0	0	87	108	0	165	2	TP
PTEN	5728	broad.mit.edu	37	10	89692901	89692901	+	Nonsense_Mutation	SNP	G	G	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr10:89692901G>T	ENST00000371953.3	+	5	1742	c.385G>T	c.(385-387)Gga>Tga	p.G129*		NM_000314.4	NP_000305.3	P60484	PTEN_HUMAN	phosphatase and tensin homolog	129	Phosphatase tensin-type.	NA	G -> E (in CD; no lipid phosphatase activity but retains protein phosphatase activity; retains ability to inhibit focal adhesion formation).|G -> R (in glioblastoma; severely reduced protein phosphatase activity; loss of phosphatase activity towards Ins(1,3,4,5)P4).		activation of mitotic anaphase-promoting complex activity|apoptosis|canonical Wnt receptor signaling pathway|cell proliferation|central nervous system development|induction of apoptosis|inositol phosphate dephosphorylation|negative regulation of cell migration|negative regulation of cyclin-dependent protein kinase activity involved in G1/S|negative regulation of focal adhesion assembly|negative regulation of G1/S transition of mitotic cell cycle|negative regulation of protein kinase B signaling cascade|negative regulation of protein phosphorylation|nerve growth factor receptor signaling pathway|phosphatidylinositol dephosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of sequence-specific DNA binding transcription factor activity|protein stabilization|regulation of neuron projection development|T cell receptor signaling pathway	cytosol|internal side of plasma membrane|PML body	anaphase-promoting complex binding|enzyme binding|inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity|lipid binding|magnesium ion binding|PDZ domain binding|phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity|phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity|phosphatidylinositol-3-phosphatase activity|protein serine/threonine phosphatase activity|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity	p.0?(37)|p.G129R(7)|p.?(5)|p.R55fs*1(5)|p.G129*(3)|p.K128_R130del(3)|p.Y27fs*1(2)|p.A121_F145del(1)|p.G127fs*5(1)|p.F56fs*2(1)|p.K128fs*47(1)		NS(28)|autonomic_ganglia(2)|biliary_tract(6)|bone(5)|breast(92)|central_nervous_system(676)|cervix(26)|endometrium(1068)|eye(8)|haematopoietic_and_lymphoid_tissue(137)|kidney(24)|large_intestine(98)|liver(20)|lung(91)|meninges(2)|oesophagus(2)|ovary(82)|pancreas(6)|prostate(129)|salivary_gland(5)|skin(127)|soft_tissue(19)|stomach(30)|testis(1)|thyroid(29)|upper_aerodigestive_tract(29)|urinary_tract(12)|vulva(17)	2771		all_cancers(4;3.61e-31)|all_epithelial(4;3.96e-23)|Prostate(4;8.12e-23)|Breast(4;0.000111)|Melanoma(5;0.00146)|all_hematologic(4;0.00227)|Colorectal(252;0.00494)|all_neural(4;0.00513)|Acute lymphoblastic leukemia(4;0.0116)|Glioma(4;0.0274)|all_lung(38;0.132)	KIRC - Kidney renal clear cell carcinoma(1;0.214)	UCEC - Uterine corpus endometrioid carcinoma (6;0.000228)|all cancers(1;4.16e-84)|GBM - Glioblastoma multiforme(1;7.77e-49)|Epithelial(1;7.67e-41)|OV - Ovarian serous cystadenocarcinoma(1;6.22e-15)|BRCA - Breast invasive adenocarcinoma(1;1.1e-06)|Lung(2;3.18e-06)|Colorectal(12;4.88e-06)|LUSC - Lung squamous cell carcinoma(2;4.97e-06)|COAD - Colon adenocarcinoma(12;1.13e-05)|Kidney(1;0.000288)|KIRC - Kidney renal clear cell carcinoma(1;0.00037)|STAD - Stomach adenocarcinoma(243;0.218)		AGCTGGAAAGGGACGAACTGG	0.408	NA	31	"""D, Mis, N, F, S"""		"""glioma,  prostate, endometrial"""	"""harmartoma, glioma,  prostate, endometrial"""		NA	Proteus syndrome;Juvenile Polyposis;Hereditary Mixed Polyposis Syndrome type 1;Cowden syndrome;Bannayan-Riley-Ruvalcaba syndrome	HNSCC(9;0.0022)|TCGA GBM(2;<1E-08)|TSP Lung(26;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	"""Cowden Syndrome, Bannayan-Riley-Ruvalcaba syndrome"""	10	10q23.3	5728	phosphatase and tensin homolog gene		"""L, E, M, O"""	66	Whole gene deletion(37)|Deletion - Frameshift(10)|Substitution - Missense(7)|Unknown(5)|Deletion - In frame(4)|Substitution - Nonsense(3)	central_nervous_system(17)|prostate(17)|skin(6)|lung(5)|ovary(5)|haematopoietic_and_lymphoid_tissue(4)|endometrium(3)|breast(3)|large_intestine(2)|thyroid(1)|cervix(1)|soft_tissue(1)|urinary_tract(1)					NA						142	131	135	NA		NA	NA	10		NA											NA				89692901		2203	4300	6503	SO:0001587	stop_gained	Familial Cancer Database	Incl.: Encephalocraniocutaneous Lipomatosis, ECCL, Proteus-like s.;incl.: Juvenile Polyposis of the Stomach;HMPS1, Colorectal Adenoma Carcinoma syndrome, CRAC, CRAC1;CS, Cowden disease, Multiple Hamartoma Syndrome, incl.: Lhermitte-Duclos; part of PTEN hamartoma tumour syndrome (PHTS) / PTEN-MATCHS, Cowden-like syndrome;subset of PTEN-Hamartoma Tumor Syndrome; incl.: Ruvalcaba-Myhre-Smith s.	ENSG00000171862	HGNC:9588	NM_000314	Approved	uc001kfb.3	NA	B2R904|O00633|O02679|Q6ICT7	ENST00000371953.3	37	CCDS31238.1	.	.	.	.	.	.	.	.	.	.	G	48	14.525609	0.99799	.	.	ENSG00000171862	ENST00000371953	.	.	.	5.22	5.22	0.72569	.	0.000000	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	.	.	.	-11.5269	18.7776	0.91918	0.0:0.0:1.0:0.0	.	.	.	.	X	129	.	.	G	+	1	0	PTEN	89682881	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	9.429000	0.97481	2.411000	0.81874	0.655000	0.94253	GGA	PTEN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049241.1	4.006819	KEEP		+	35.234875	0.08046	14	160	---	---	---	---	1	0.8839632	2	48	0	238	16	201	0	238	2	1	0.9985609	16	225	1	552	16	201	0	238	5	TP
TTC17	55761	broad.mit.edu	37	11	43464880	43464880	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr11:43464880G>A	ENST00000039989.4	+	17	2271	c.2257G>A	c.(2257-2259)Gtg>Atg	p.V753M	TTC17_ENST00000299240.6_Missense_Mutation_p.V810M|TTC17_ENST00000526774.1_3'UTR	NM_018259.5	NP_060729.2	Q96AE7	TTC17_HUMAN	tetratricopeptide repeat domain 17	753		NA					binding			breast(1)|cervix(1)|endometrium(4)|kidney(2)|large_intestine(7)|lung(27)|ovary(5)|prostate(3)|skin(3)	53						TTCAGGTACGGTGGTTGAGGA	0.443	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						105	101	103	NA		NA	NA	11		NA											NA				43464880		2203	4300	6503	SO:0001583	missense			ENSG00000052841	HGNC:25596	NM_018259	Approved	uc001mxi.3	NA		ENST00000039989.4	37	CCDS31466.1	.	.	.	.	.	.	.	.	.	.	G	19.07	3.755642	0.69648	.	.	ENSG00000052841	ENST00000299240;ENST00000039989	T;T	0.45276	0.9;1.2	5.7	5.7	0.88788	.	0.000000	0.85682	D	0.000000	T	0.50411	0.1614	L	0.32530	0.975	0.45662	D	0.998581	D;D;D	0.69078	0.995;0.961;0.997	P;P;P	0.62014	0.793;0.556;0.897	T	0.34204	-0.9838	10	0.31617	T	0.26	-16.4863	16.1142	0.81289	0.0:0.1336:0.8664:0.0	.	810;753;810	Q8NEC0;Q96AE7;G3XAB3	.;TTC17_HUMAN;.	M	810;753	ENSP00000299240:V810M;ENSP00000039989:V753M	ENSP00000039989:V753M	V	+	1	0	TTC17	43421456	1.000000	0.71417	1.000000	0.80357	0.901000	0.52897	6.480000	0.73604	2.697000	0.92050	0.557000	0.71058	GTG	TTC17-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000389577.2	135.702493	KEEP		+	136.848532	0.390909	43	67	---	---	---	---	1	1	16	34	0	108	56	91	0	108	2	0	0	0	0	0	0	56	91	0	108	2	TP
RELT	84957	broad.mit.edu	37	11	73102204	73102204	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr11:73102204G>C	ENST00000064780.2	+	5	564	c.303G>C	c.(301-303)tgG>tgC	p.W101C	RELT_ENST00000393580.2_Missense_Mutation_p.W101C	NM_152222.1	NP_689408.1	Q969Z4	TR19L_HUMAN	RELT tumor necrosis factor receptor	101		NA				cytoplasm|integral to membrane|plasma membrane	binding|receptor activity			NS(1)|central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(3)|upper_aerodigestive_tract(1)	12						TTGGGCCTTGGGGGGTTCCCC	0.587	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						151	138	142	NA		NA	NA	11		NA											NA				73102204		2200	4293	6493	SO:0001583	missense				HGNC:13764	NM_032871	Approved	uc001otv.3	NA	Q86V34|Q96JU1|Q9BUX7	ENST00000064780.2	37	CCDS8222.1	.	.	.	.	.	.	.	.	.	.	G	12.44	1.937299	0.34189	.	.	ENSG00000054967	ENST00000064780;ENST00000545687;ENST00000393580	T;T;T	0.80653	-0.86;-1.4;-0.86	5.28	-0.0453	0.13852	.	1.092350	0.06947	N	0.813881	T	0.62097	0.2400	N	0.19112	0.55	0.09310	N	1	B	0.30664	0.289	B	0.28305	0.088	T	0.52426	-0.8577	10	0.41790	T	0.15	2.9408	0.5003	0.00578	0.284:0.1864:0.3411:0.1885	.	101	Q969Z4	TR19L_HUMAN	C	101	ENSP00000064780:W101C;ENSP00000439352:W101C;ENSP00000377207:W101C	ENSP00000064780:W101C	W	+	3	0	RELT	72779852	0.001000	0.12720	0.008000	0.14137	0.380000	0.30137	0.026000	0.13599	0.154000	0.19237	0.655000	0.94253	TGG	RELT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000397380.2	13.160633	KEEP		+	15.253062	0.2	5	20	---	---	---	---	1	0.9967749	9	31	0	231	8	26	0	231	2	0	0	0	0	0	0	8	26	0	231	2	TP
CLYBL	171425	broad.mit.edu	37	13	100425234	100425234	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr13:100425234C>G	ENST00000376355.3	+	2	250	c.219C>G	c.(217-219)gaC>gaG	p.D73E	CLYBL_ENST00000376354.1_Missense_Mutation_p.D73E|CLYBL_ENST00000339105.4_Missense_Mutation_p.D73E|CLYBL_ENST00000444838.2_Missense_Mutation_p.D73E|CLYBL_ENST00000376360.1_Missense_Mutation_p.D73E	NM_206808.2	NP_996531.1	Q8N0X4	CLYBL_HUMAN	citrate lyase beta like	73		NA			cellular aromatic compound metabolic process	citrate lyase complex|mitochondrion	citrate (pro-3S)-lyase activity|metal ion binding			NS(1)|kidney(6)|large_intestine(6)|lung(10)|skin(2)	25	all_neural(89;0.0837)|Medulloblastoma(90;0.18)|Lung SC(71;0.184)					CAGTGCTCGACTGTGAGGATG	0.398	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						102	99	100	NA		NA	NA	13		NA											NA				100425234		2203	4300	6503	SO:0001583	missense			ENSG00000125246	HGNC:18355		Approved	uc001vok.3	NA	Q5W0F7|Q8TDH8	ENST00000376355.3	37		.	.	.	.	.	.	.	.	.	.	C	16.25	3.069525	0.55539	.	.	ENSG00000125246	ENST00000376355;ENST00000376360;ENST00000444838;ENST00000376354;ENST00000339105	T;T;T;T;T	0.65178	-0.14;-0.14;-0.14;-0.14;-0.14	5.32	3.58	0.41010	Aldehyde-lyase domain (1);Pyruvate/Phosphoenolpyruvate kinase (2);	0.000000	0.85682	D	0.000000	T	0.80210	0.4581	M	0.92268	3.29	0.49299	D	0.999772	D;P;P	0.59357	0.985;0.814;0.845	D;B;P	0.63192	0.912;0.333;0.773	T	0.81415	-0.0943	10	0.59425	D	0.04	16.8327	10.0518	0.42221	0.0:0.7802:0.0:0.2198	.	73;73;73	B4DU60;Q8N0X4-2;Q8N0X4	.;.;CLYBL_HUMAN	E	73	ENSP00000365533:D73E;ENSP00000365538:D73E;ENSP00000404768:D73E;ENSP00000365532:D73E;ENSP00000342991:D73E	ENSP00000342991:D73E	D	+	3	2	CLYBL	99223235	1.000000	0.71417	1.000000	0.80357	0.970000	0.65996	2.736000	0.47385	0.623000	0.30267	0.462000	0.41574	GAC	CLYBL-201	KNOWN	basic	protein_coding	NA	protein_coding		26.42732	KEEP		+	50.153385	0.1125	18	142	---	---	---	---	1	0.9185095	2	33	0	132	27	206	0	132	2	0	0	0	0	0	0	27	206	0	132	2	TP
ATP11A	23250	broad.mit.edu	37	13	113485796	113485796	+	Silent	SNP	C	C	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr13:113485796C>T	ENST00000487903.1	+	13	1417	c.1329C>T	c.(1327-1329)aaC>aaT	p.N443N	ATP11A_ENST00000283558.8_Silent_p.N443N|ATP11A_ENST00000375630.2_Silent_p.N443N|ATP11A_ENST00000375645.3_Silent_p.N443N			P98196	AT11A_HUMAN	ATPase, class VI, type 11A	443		NA			ATP biosynthetic process	integral to membrane	ATP binding|ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism|magnesium ion binding|phospholipid-translocating ATPase activity			NS(1)|central_nervous_system(3)|cervix(1)|endometrium(6)|kidney(4)|large_intestine(12)|lung(17)|ovary(4)|skin(1)|stomach(1)|urinary_tract(1)	51	all_lung(23;0.000374)|Lung NSC(43;0.0107)|Lung SC(71;0.0753)|all_neural(89;0.0804)|Hepatocellular(20;0.0877)|Medulloblastoma(90;0.163)	all_lung(25;0.134)|all_epithelial(44;0.141)				TCATCTGCAACGGGCAGGTCC	0.587	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						159	112	128	NA		NA	NA	13		NA											NA				113485796		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000068650	HGNC:13552	NM_015205	Approved	uc001vsj.4	NA	Q5VXT2	ENST00000487903.1	37	CCDS32011.1	.	.	.	.	.	.	.	.	.	.	C	8.907	0.957737	0.18507	.	.	ENSG00000068650	ENST00000418678	.	.	.	5.45	-0.104	0.13605	.	.	.	.	.	T	0.55545	0.1927	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.48399	-0.9039	4	.	.	.	.	9.1559	0.36992	0.0:0.3608:0.0:0.6392	.	.	.	.	M	418	.	.	T	+	2	0	ATP11A	112533797	0.433000	0.25562	0.996000	0.52242	0.765000	0.43378	-0.378000	0.07446	-0.047000	0.13423	0.561000	0.74099	ACG	ATP11A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000045834.3	120.301325	KEEP		+	121.727208	0.375	39	65	---	---	---	---	1	0.9995809	8	19	0	87	45	86	0	87	2	0	0	0	0	0	0	45	86	0	87	2	TP
MYH7	4625	broad.mit.edu	37	14	23883029	23883029	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr14:23883029G>A	ENST00000355349.3	-	39	5891	c.5729C>T	c.(5728-5730)gCg>gTg	p.A1910V	CTD-2201G16.1_ENST00000557368.1_RNA	NM_000257.2	NP_000248.2	P12883	MYH7_HUMAN	myosin, heavy chain 7, cardiac muscle, beta	1910		NA			adult heart development|muscle filament sliding|regulation of heart rate|ventricular cardiac muscle tissue morphogenesis	focal adhesion|muscle myosin complex|myosin filament|nucleus|sarcomere	actin binding|actin-dependent ATPase activity|ATP binding|calmodulin binding|microfilament motor activity|structural constituent of muscle			NS(3)|breast(4)|central_nervous_system(2)|cervix(2)|endometrium(14)|haematopoietic_and_lymphoid_tissue(3)|kidney(5)|large_intestine(19)|lung(57)|ovary(5)|prostate(9)|skin(5)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(5)	137	all_cancers(95;2.54e-05)			GBM - Glioblastoma multiforme(265;0.00725)		GGCGATGTCCGCCCGCTCCTC	0.622	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						122	110	114	NA		NA	NA	14		NA											NA				23883029		2203	4300	6503	SO:0001583	missense			ENSG00000092054	HGNC:7577	NM_000257	Approved	uc001wjx.3	NA	A2TDB6|B6D424|Q14836|Q14837|Q14904|Q16579|Q2M1Y6|Q92679|Q9H1D5|Q9UDA2|Q9UMM8	ENST00000355349.3	37	CCDS9601.1	.	.	.	.	.	.	.	.	.	.	G	35	5.472092	0.96274	.	.	ENSG00000092054	ENST00000355349;ENST00000544444	D	0.82619	-1.63	5.6	5.6	0.85130	Myosin tail (1);	.	.	.	.	D	0.94788	0.8317	H	0.97682	4.055	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	D	0.96096	0.9065	9	0.66056	D	0.02	.	19.1973	0.93695	0.0:0.0:1.0:0.0	.	1910	P12883	MYH7_HUMAN	V	1910;1915	ENSP00000347507:A1910V	ENSP00000347507:A1910V	A	-	2	0	MYH7	22952869	1.000000	0.71417	0.957000	0.39632	0.796000	0.44982	9.657000	0.98554	2.653000	0.90120	0.561000	0.74099	GCG	MYH7-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000071798.3	39.812215	KEEP		-	48.576999	0.1875	18	78	---	---	---	---	1	0.9894503	5	26	0	122	24	91	0	122	2	0	0	0	0	0	0	24	91	0	122	2	TP
LTBP2	4053	broad.mit.edu	37	14	74992813	74992813	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr14:74992813G>A	ENST00000261978.4	-	14	2779	c.2393C>T	c.(2392-2394)aCg>aTg	p.T798M	LTBP2_ENST00000556690.1_Missense_Mutation_p.T798M	NM_000428.2	NP_000419.1	Q14767	LTBP2_HUMAN	latent transforming growth factor beta binding protein 2	798		NA			protein secretion|protein targeting|transforming growth factor beta receptor signaling pathway	extracellular space|proteinaceous extracellular matrix	calcium ion binding|growth factor binding			breast(3)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(9)|liver(1)|lung(29)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	58				BRCA - Breast invasive adenocarcinoma(234;0.00219)|READ - Rectum adenocarcinoma(1;0.0649)		GACACTGGTCGTGACCTGCAC	0.577	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						115	90	98	NA		NA	NA	14		NA											NA				74992813		2203	4300	6503	SO:0001583	missense				HGNC:6715	NM_000428	Approved	uc001xqa.3	NA	Q99907|Q9NS51	ENST00000261978.4	37	CCDS9831.1	.	.	.	.	.	.	.	.	.	.	G	6.894	0.534496	0.13188	.	.	ENSG00000119681	ENST00000261978;ENST00000556690;ENST00000556359	T;T	0.78816	-1.21;-1.21	4.57	2.68	0.31781	.	0.409284	0.18240	N	0.147279	T	0.61862	0.2381	L	0.29908	0.895	0.09310	N	1	B	0.17852	0.024	B	0.10450	0.005	T	0.48768	-0.9006	10	0.33940	T	0.23	.	5.6037	0.17367	0.0987:0.0:0.7079:0.1935	.	798	Q14767	LTBP2_HUMAN	M	798;798;58	ENSP00000261978:T798M;ENSP00000451477:T798M	ENSP00000261978:T798M	T	-	2	0	LTBP2	74062566	0.654000	0.27367	0.020000	0.16555	0.419000	0.31324	0.897000	0.28390	0.806000	0.34183	-0.137000	0.14449	ACG	LTBP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000413595.1	20.35108	KEEP		-	20.370855	0.545455	6	5	---	---	---	---	1	0.9984208	3	14	0	37	7	5	0	37	2	0	0	0	0	0	0	7	5	0	37	2	TP
ZNF599	148103	broad.mit.edu	37	19	35250777	35250777	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr19:35250777G>T	ENST00000329285.7	-	4	1302	c.929C>A	c.(928-930)cCc>cAc	p.P310H		NM_001007248.2	NP_001007249.1	Q96NL3	ZN599_HUMAN	zinc finger protein 599	310		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			endometrium(3)|large_intestine(10)|lung(8)|ovary(1)|pancreas(1)|skin(1)	24	all_lung(56;1.13e-07)|Lung NSC(56;1.81e-07)|Esophageal squamous(110;0.162)		LUSC - Lung squamous cell carcinoma(66;0.138)			GCATAAAAAGGGTTTTTCTCG	0.418	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						98	108	105	NA		NA	NA	19		NA											NA				35250777		2203	4300	6503	SO:0001583	missense				HGNC:26408	XM_086046	Approved	uc010edn.1	NA	Q569K0|Q5PRG1	ENST00000329285.7	37	CCDS32991.1	.	.	.	.	.	.	.	.	.	.	G	13.14	2.149413	0.37923	.	.	ENSG00000153896	ENST00000392231;ENST00000329285	T	0.17528	2.27	2.36	1.26	0.21427	Zinc finger, C2H2 (1);Zinc finger, C2H2-type/integrase, DNA-binding (1);	.	.	.	.	T	0.47116	0.1428	M	0.93854	3.465	0.40488	D	0.980516	D	0.89917	1.0	D	0.91635	0.999	T	0.54497	-0.8285	9	0.87932	D	0	.	8.9088	0.35541	0.0:0.2324:0.7675:0.0	.	310	Q96NL3	ZN599_HUMAN	H	309;310	ENSP00000333802:P310H	ENSP00000333802:P310H	P	-	2	0	ZNF599	39942617	0.996000	0.38824	0.974000	0.42286	0.965000	0.64279	2.594000	0.46189	0.528000	0.28580	0.491000	0.48974	CCC	ZNF599-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000460648.1	71.885432	KEEP		-	75.550399	0.290323	27	66	---	---	---	---	1	0.6738809	5	3	0	210	28	77	0	210	2	0	0	0	0	0	0	28	77	0	210	2	TP
CCDC8	83987	broad.mit.edu	37	19	46914658	46914658	+	Silent	SNP	C	C	T			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr19:46914658C>T	ENST00000307522.3	-	1	2183	c.1410G>A	c.(1408-1410)agG>agA	p.R470R		NM_032040.4	NP_114429.2	Q9H0W5	CCDC8_HUMAN	coiled-coil domain containing 8	470		NA				plasma membrane				breast(1)|central_nervous_system(1)|endometrium(1)|large_intestine(4)|lung(10)|ovary(3)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)	23				OV - Ovarian serous cystadenocarcinoma(262;4.66e-05)|all cancers(93;0.000582)|Epithelial(262;0.00428)|GBM - Glioblastoma multiforme(486;0.0421)		GTTTCCGGGCCCTGGCTCCTG	0.612	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						56	59	58	NA		NA	NA	19		NA											NA				46914658		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000169515	HGNC:25367	NM_032040	Approved	uc002pep.3	NA	Q8TB26	ENST00000307522.3	37	CCDS12685.1	.	.	.	.	.	.	.	.	.	.	C	13.78	2.337806	0.41398	.	.	ENSG00000169515	ENST00000540252	.	.	.	3.98	-2.05	0.07321	.	.	.	.	.	T	0.27933	0.0688	.	.	.	0.09310	N	0.999991	.	.	.	.	.	.	T	0.33343	-0.9872	5	0.21540	T	0.41	-10.9807	8.594	0.33703	0.0:0.4347:0.0:0.5653	.	.	.	.	E	317	.	ENSP00000441180:G317E	G	-	2	0	CCDC8	51606498	.	.	0.002000	0.10522	0.979000	0.70002	.	.	-0.223000	0.09943	0.555000	0.69702	GGG	CCDC8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000368598.1	33.548454	KEEP		-	33.587942	0.454545	10	12	---	---	---	---	1	1	46	44	0	118	14	17	0	118	2	0	0	0	0	0	0	14	17	0	118	2	TP
ANKEF1	63926	broad.mit.edu	37	20	10018910	10018910	+	5'UTR	SNP	A	A	G			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr20:10018910A>G	ENST00000378380.3	+	0	290				SNAP25-AS1_ENST00000603542.1_RNA|SNAP25-AS1_ENST00000421143.2_RNA|ANKEF1_ENST00000488991.1_3'UTR|ANKEF1_ENST00000378392.1_5'UTR|SNAP25-AS1_ENST00000438646.1_RNA	NM_198798.1	NP_942093.1			ankyrin repeat and EF-hand domain containing 1	NA		NA									NA						CTTCAGCTTTAGTTTTGGTCC	0.323	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						23	23	23	NA		NA	NA	20		NA											NA				10018910		2181	4290	6471	SO:0001623	5_prime_UTR_variant			ENSG00000132623	HGNC:15803	NM_022096	Approved		NA		ENST00000378380.3	37	CCDS13108.1																																																																																			ANKEF1-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000077968.2	11.493473	KEEP		+	12.231039	0.266667	4	11	---	---	---	---	1	0.810628	2	9	0	50	4	11	0	50	2	0	0	0	0	0	0	4	11	0	50	2	TP
PHF20	51230	broad.mit.edu	37	20	34526877	34526877	+	Silent	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr20:34526877G>A	ENST00000374012.3	+	16	2688	c.2559G>A	c.(2557-2559)caG>caA	p.Q853Q	PHF20_ENST00000439301.1_3'UTR			Q9BVI0	PHF20_HUMAN	PHD finger protein 20	853		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	MLL1 complex	DNA binding|zinc ion binding			breast(5)|endometrium(1)|kidney(7)|large_intestine(6)|lung(11)|ovary(3)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	39	Breast(12;0.00631)|all_lung(11;0.0145)					CCGTGGAGCAGAAGCTGGTGG	0.647	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						53	47	49	NA		NA	NA	20		NA											NA				34526877		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000025293	HGNC:16098	NM_016436	Approved	uc002xek.1	NA	A7E235|B2RB56|E1P5S3|Q5JWY9|Q9BWV4|Q9BXA3|Q9BZW3|Q9H421|Q9H4J6|Q9NZ22	ENST00000374012.3	37	CCDS13268.1																																																																																			PHF20-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000078949.2	20.244312	KEEP		+	23.225591	0.219512	9	32	---	---	---	---	1	0.9777348	10	21	0	120	12	51	0	120	2	0	0	0	0	0	0	12	51	0	120	2	TP
SEMG1	6406	broad.mit.edu	37	20	43836560	43836560	+	Missense_Mutation	SNP	C	C	T	rs141417035	by1000genomes	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr20:43836560C>T	ENST00000372781.3	+	2	679	c.622C>T	c.(622-624)Cgt>Tgt	p.R208C	SEMG1_ENST00000244069.6_Missense_Mutation_p.R208C	NM_003007.3	NP_002998.1			semenogelin I	NA		NA								cervix(1)|endometrium(2)|kidney(3)|large_intestine(3)|liver(1)|lung(12)|prostate(1)|skin(6)|stomach(2)|urinary_tract(1)	32		Myeloproliferative disorder(115;0.0122)				CAAACAACAACGTGAGACTAA	0.403	NA	NA						NA					C	1	5e-04	NA	NA	2184	0.0017	1	,	,	NA	3e-04	NA	NA	NA	5e-04	1	LOWCOV,EXOME	NA	NA	6e-04	SNP						NA		NA				0							NA						88	79	82	NA		NA	NA	20		NA											NA				43836560		2203	4300	6503	SO:0001583	missense			ENSG00000124233	HGNC:10742	NM_003007	Approved		NA		ENST00000372781.3	37	CCDS13345.1	1	4.578754578754579E-4	0	0.0	0	0.0	1	0.0017482517482517483	0	0.0	C	9.753	1.168041	0.21621	.	.	ENSG00000124233	ENST00000244069;ENST00000372781	T;T	0.11385	2.78;2.78	1.17	-2.34	0.06704	.	.	.	.	.	T	0.20129	0.0484	L	0.51422	1.61	0.09310	N	1	D;D;D	0.89917	0.998;1.0;0.999	P;D;P	0.68483	0.804;0.958;0.877	T	0.09314	-1.0680	9	0.59425	D	0.04	.	6.5402	0.22377	0.3334:0.6666:0.0:0.0	.	208;208;208	P04279-2;P04279;E7EPD3	.;SEMG1_HUMAN;.	C	208	ENSP00000244069:R208C;ENSP00000361867:R208C	ENSP00000244069:R208C	R	+	1	0	SEMG1	43269974	0.000000	0.05858	0.000000	0.03702	0.001000	0.01503	-0.036000	0.12185	-1.326000	0.02266	-0.602000	0.04101	CGT	SEMG1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000079416.3	58.846017	KEEP		+	61.796967	0.287671	21	52	---	---	---	---	0	0	0	0	0	141	27	65	0	141	2	1	1	170	247	2	544	27	65	0	141	6	TP
PWP2	5822	broad.mit.edu	37	21	45550662	45550662	+	3'UTR	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr21:45550662G>A	ENST00000291576.7	+	0	2896				C21orf33_ENST00000427803.2_5'Flank|C21orf33_ENST00000348499.5_5'Flank|C21orf33_ENST00000291577.6_5'Flank	NM_005049.2	NP_005040.2	Q15269	PWP2_HUMAN	PWP2 periodic tryptophan protein homolog (yeast)	NA		NA				cytoplasm|nucleolus	signal transducer activity			cervix(1)|endometrium(6)|large_intestine(6)|lung(4)|pancreas(1)|prostate(1)|stomach(1)|urinary_tract(1)	21				STAD - Stomach adenocarcinoma(101;0.172)|Colorectal(79;0.2)		AGAGCCAGCCGGTTGCAGCGT	0.577	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA	G		0,4406		0,0,2203	81	81	81	NA		-3.2	0	21		81	1,8599	1.2+/-3.3	0,1,4299	no	utr-3	PWP2	NM_005049.2		0,1,6502	AA,AG,GG	NA	0.0116,0.0,0.0077			45550662	1,13005	2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000241945	HGNC:9711	NM_005049	Approved	uc002zeb.3	NA	B2RAG8|Q96A77	ENST00000291576.7	37	CCDS33579.1																																																																																			PWP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000195736.3	40.864505	KEEP		+	41.822677	0.333333	13	26	---	---	---	---	1	1	42	102	0	183	19	36	0	183	2	0	0	0	0	0	0	19	36	0	183	2	TP
EFCAB6	64800	broad.mit.edu	37	22	43933388	43933388	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-32-2632-Tumor-SM-17P2L	GBM-TCGA-32-2632-Normal-SM-1QXY1	g.chr22:43933388G>A	ENST00000262726.7	-	29	4170	c.3917C>T	c.(3916-3918)cCc>cTc	p.P1306L	EFCAB6_ENST00000396231.2_Missense_Mutation_p.P1154L|EFCAB6_ENST00000461800.1_5'UTR|EFCAB6-AS1_ENST00000431327.2_RNA	NM_022785.3	NP_073622.2	Q5THR3	EFCB6_HUMAN	EF-hand calcium binding domain 6	1306	Interaction with PARK7.	NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	calcium ion binding			breast(1)|cervix(1)|endometrium(6)|kidney(2)|large_intestine(16)|lung(25)|ovary(4)|pancreas(1)|prostate(4)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	68		Ovarian(80;0.0247)|all_neural(38;0.025)				GTTCTGCAAGGGTGGAGTGCC	0.517	NA	NA						NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA				0							NA						66	67	66	NA		NA	NA	22		NA											NA				43933388		2203	4300	6503	SO:0001583	missense			ENSG00000186976	HGNC:24204	NM_022785	Approved	uc003bdy.2	NA	A8K8P6|A8K8Y3|B0QYI4|B0QYI6|Q5U5T6|Q9BY88|Q9H5C4|Q9NSF5	ENST00000262726.7	37	CCDS14049.1	.	.	.	.	.	.	.	.	.	.	G	20.2	3.955455	0.73902	.	.	ENSG00000186976	ENST00000396231;ENST00000262726	T;T	0.24538	1.87;1.85	4.71	4.71	0.59529	EF-hand calcium-binding domain-containing protein 6 (1);	0.170736	0.37095	N	0.002256	T	0.49932	0.1586	M	0.72118	2.19	0.80722	D	1	D	0.89917	1.0	D	0.85130	0.997	T	0.49934	-0.8886	10	0.45353	T	0.12	-6.6055	15.4299	0.75084	0.0:0.0:1.0:0.0	.	1306	Q5THR3	EFCB6_HUMAN	L	1154;1306	ENSP00000379533:P1154L;ENSP00000262726:P1306L	ENSP00000262726:P1306L	P	-	2	0	EFCAB6	42264721	0.264000	0.24093	0.050000	0.19076	0.288000	0.27193	0.858000	0.27845	2.155000	0.67459	0.655000	0.94253	CCC	EFCAB6-010	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000353176.1	51.512528	KEEP		-	56.139369	0.24	18	57	---	---	---	---	1	0.2723109	3	1	0	141	24	72	0	141	2	0	0	0	0	0	0	24	72	0	141	2	TP
